Adaptive Biotechnologies (ADPT) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $19.34 --0%
Revenue Growth %: +11.8%
Financial Fact:
Benefit from (provision for) income taxes: 2.06M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +11.8%
Financial Fact:
Benefit from (provision for) income taxes: 2.06M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q3 EPS of ($0.35), $0.01 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $37.92 million versus the consensus estimate of $42.96 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays sees global expansion intact, warns against market complacency
- Darden Restaurants (DRI) Tops Q4 EPS by 3c, Misses on Revenue; Offers FY27 Guidance
- Agilent completes acquisition of Biocare Medical
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
